Leaders
Dr. Kriti Israni:Furthering Indian Pharma Through Effective Consulting
Dr. Kriti Israni
Founder & Ceo, Quality In Core
Confronted With Significant Health Needs, The Pharma Sector Is Evolving Rapidly, Working Through New Treatment Modalities, Smart Machines, Advanced Analytics, And Digital Connectivity. And, Throughout History, As Women Have Been Witnessed To Be Making Significant Contributions To Diverse Industries, Medicine Also Counts In. Today, Amongst The Many Women Leaders Proving Their Leadership Mettle In The Space, Dr. Kriti Chopra Israni (Founder/Ceo Of Quality In Core- Qic), Is One Who Stands Indifferent, Providing World-Class Consulting Services And Cost-Effective Solutions In Pharmaceutical, Medical Device, Medical Diagnostics, Life Sciences, Healthcare, And Biotechnology Industries Through Her Firm Qic- An Iso 9001 Certified Global Consulting Service Company.
Kriti Moving To Us At The Age Of 18, Pursued Her Bachelor's In Biochemistry & Biotechnology From Michigan State University, And Completed Master's In Biotechnology From Northwestern University, Chicago. Being Quite Focused, At The Age Of 19, She Plunged Into Her Career Journey Doing Part-Time And Full-Time Internships Alongside Her Education. Working With Companies Like Abbott Labs, Abbvie, And Stepan Company During The Time, She Also Served As A Research Assistant Performing Researches Like Plant, Animal, And Human Stemcell Research. Post Her Masters, She Was Deployed With Pfizer And Hospira In The Area Of Quality And Validation Where Her Role Involved A Lot Of People-Interaction, Setting-Up Practices, Conducting Training, Audits And Helping Them With Warning Letter, Including Any Challenges Faced In Lab Testing Or Product Testing Or Manufacturing. After Getting A Significant Experience, She Started Her Own Firm- Qic In The Year 2016, Realizing Her Tend Towards People-Connect. Kriti Engages In An Exclusive Interaction With Women Entrepreneur Magazine.
What Motivated You To Establish Quality In Core? Tell Us About The Underlying Idea Behind The Venture.
I Tried Different Areas, Before I Realized My Heart Lies In Working With People Directly And Making A Difference. Professionally, I Work With Us Fda Compliances. I Realized That India Was Way Behind In Quality, Validation And Compliances, Despite Being The Most Labour Efficient &Cost-Effective Industry For Manufacturing Due To The Lack Of Work Ethics, Knowledge, And How To Implement Compliances. Bridging This Huge Gap Between India & Rest Of The World, And Respectively Boosting The India Pharma Industry, I Incepted Qic.
Tell Us About Some Of The Challenges You Encountered As A Business Leader In The Pharma Consulting Business Landscape And How You Overcome Them.
Undoubtedly, There Are Numerous Challenges. Mainly, There’s A Cultural Issue, Which I Faced As Everyone Here Ends Up Having A Lack Of Trust And Lack Of Teamwork To Some Extent. I Connect With People In One-On-One Interaction, And Ensure To Make Them Comfortable First. I Help Clients Realize That We Are Here To Not Just Dictate But Solve Problems And Work Together Towards Practical Solutions.
Mention Some Of The Key Milestones You Have Achieved Throughout Your Professional Journey. What Has Been Your Mantra For Success As A Business Leader?
Sure! So There Are A Couple Of Things In That Aspect. First Was When Back In The Time At Hospira & Pfizer Being The Youngest, 23, In Corporate Quality & Validation, I Was Given The Opportunity To Lead 14 Different Sites Performing As The Direct Point Of Contact With The Vice Presidents From Different Areas. I Was Rather Humbled To Be Given These Responsibilities. I Was Also Recognized In The Top One Percent As An ‘Employee Of The Year’. Later. I Founded Qic In 2016. For Me To Work As A Consultant Even Employed With Pfizer & Hospira Was A Challenge, Amidst All Men Space. There Was A Lot Of Reluctance From Even The Site Quality Heads, But Eventually With Qic, The Trust Became So Much With All That One Of The Site Head Endedup Having Personal Meeting With Me And Offering Me A Job, Or Rather Training Her Daughter At Qic To Acquire The Same Level Of Industry Experience Like Me. My Mantra For Success: One Step At A Time And Win-Win Situation.
Going Forward How Do You See The Indian Pharmaceutical Landscape Changing And Evolving And You See Any Specific Industry Trends Developing In The Market Which You Think Will Have A Significant Impact?
Including The Global Pharma Landscape, The Indian Pharma Industry Has Been Evolving Since The Beginning Of Time. Though Covid-19 Was A Huge Disruptor, Even Then The Pharmaceutical Sector Picked Up The Minute The Vaccine Started Forming. Also, As The Indian Market Is The Cheapest, With The Most Hardworking And Brainy Population, Mncs Want To Open A Manufacturing Plant Here Or Have Already Opened With A Mindset Such That They Can Create More Profit Here. So, What I Foresee Is That Indian Market Will Always Be The Biggest And Is Set To Scale Magnanimously In Future.
"Always Keep The Big Picture In Mind, While Focussing On Daily Tasks And Moving In Positive Direction. Focus On ‘One Step At A Time’, And Ensure ‘Win-Win’ Situation For All."
What Is The Vision For The Future Ahead?
During Covid Times, We Had Reduced Our Travelling Although I Had Opened A Qic Sister Company In Us In 2020 And Was Handling Remote Work. Becoming A Parent, In 2020 And Again In 2022, I Realized A Huge Gap In The Parenting Culture And Had My Calling To Support Parents And Children. This Led To Me Diving In The Field Of Child Nutrition, Holistic Health And Parent Counselling. In 2022, I Founded- Hale & Hearty Kids, Focussed On Helping Parents To Raise Healthier Kids, Happier Homes. I Plan To Sail Further With Prominent Plans In Store For Qic And Hale & Hearty Kids, Working For People’s Betterment.
Any Advice For The Upcoming Leaders Or Entrepreneurs?
Always Keep The Big Picture In Mind, While Focussing On Daily Tasks And Moving In Positive Direction. Focus On ‘One Step At A Time’, And Ensure ‘Win-Win’ Situation For All.
Dr. Kriti Israni Founder & Ceo, Quality In Core
A Passionate Pharma & Life Sciences Doyen Committed To Boosting The Indian Pharma & Life Sciences Space